Authors: GARVEY CW GARVEY TQ

Citation: Cw. Garvey et Tq. Garvey, ANTIHYPERTENSIVE THERAPY - RECOMMENDATIONS AND REALITIES, JAMA, the journal of the American Medical Association, 279(10), 1998, pp. 746-747

Authors: CLEMENTI WA GARVEY TQ CLIFTON GD MCCOY RA BRANDT S SCHWARTZ S

Citation: Wa. Clementi et al., SINGLE-DOSE PHARMACOKINETICS OF (S)-ATENOLOL ADMINISTERED ORALLY AS ASINGLE ENANTIOMER FORMULATION AND AS A RACEMIC-MIXTURE (TENORMIN(TM), Chirality, 6(3), 1994, pp. 169-174

Authors: MCCOY RA CLIFTON GD CLEMENTI WA SMITH MD GARVEY TQ WERMELING DP SCHWARTZ SE

Citation: Ra. Mccoy et al., PHARMACODYNAMICS OF RACEMIC AND S(-)-ATENOLOL IN HUMANS, Journal of clinical pharmacology, 34(8), 1994, pp. 816-822

Authors: HYMAN PE DILORENZO C MCADAMS L FLORES AF TOMOMASA T GARVEY TQ

Citation: Pe. Hyman et al., PREDICTING THE CLINICAL-RESPONSE TO CISAPRIDE IN CHILDREN WITH CHRONIC INTESTINAL PSEUDOOBSTRUCTION, The American journal of gastroenterology, 88(6), 1993, pp. 832-836